Quality of life in patients with locally advanced head and neck cancer treated with chemoradiotherapy. Comparison of two protocols using the EORTC questionnaires (QLQ-C30, H&N35)

被引：0

作者：

Urdaniz J.I.A. ^{[1
]}

De La Vega F.A. ^{[1
]}

Burgaleta A.M. ^{[1
]}

García R.V. ^{[1
]}

Aguillo M.M. ^{[1
]}

Pascual E.S. ^{[1
]}

López E.M. ^{[1
]}

机构：

[1] Servicio de Oncología, Hospital de Navarra, 31007 Pamplona, C/ Monasterio de Urdax

来源：

Clinical and Translational Oncology | 2005年 / 7卷 / 9期

关键词：

Chemotherapy; Evaluation; Head and neck cancer; Quality of life; Radiotherapy;

D O I：

10.1007/BF02716585

中图分类号：

学科分类号：

摘要：

Introduction. The objective of this study is to assess the quality of life (QoL) of two groups of patients during treatment for locally advanced head and neck (H&N) cancer. Material and methods. Two samples of 30 patients each in AJCC stages III and IV undergoing either of two chemo-radiotherapy protocols completed the EORTC QLQ-C30 general questionnaire and the QLQ-H&N35 H&N module on three occasions during the treatment and follow-up periods. We also collected clinical data. The QoL scores and their evolution over the three measurements were calculated and both protocols were compared during the treatment period. Results. The QoL scores are acceptable in general. Limitations were observed in relation to toxicity, psycho-social and some functional areas during the treatment. QoL improved in the follow-up period. The clinical and QoL data are better in one of the two treatment protocols. Discussion. The QoL scores indicate that the condition of the patients receiving the protocols was acceptable, considering the severity of their disease. The treatments were reasonably-well tolerated.

引用

页码：398 / 403

页数：5

共 24 条

[1]

Aaronson N.K., Cull A., Kaasa S., Sprangers M., The EORTC modular approach to Quality of Life assessment in Oncology, Int J Ment Health, 23, 2, pp. 75-96, (1994)

[2]

Kiebert G., Kaasa S., Quality of Life in clinical trials: Experience and perspective of the EORTC, J Natl Cancer Inst, 85, pp. 365-376, (1993)

[3]

De Graeff A., De Leeuw J., Ros W., Hordijk G., Blijham G., Winnubst J., A prospective study on Quality of Life of patients with cancer of the oral cavity or oropharynx treated with surgery with or without radiotherapy, Oral Oncol, 35, pp. 27-32, (1999)

[4]

Janda M., Newman B., Obermair A., Et al., Impaired quality of life in patients commencing radiotherapy for cancer, Strahlenther Onkol, 180, 2, pp. 78-83, (2004)

[5]

Moyer J.S., Wolf G.T., Bradford C.R., Current thoughts on the role of chemotherapy and radiation in advanced head and neck cancer, Curr Opin Otolaryngol Head Neck Surg, 12, 2, pp. 82-87, (2004)

[6]

Cohen E.E., Lingen M.W., Vokes E.E., The expanding role of systemic therapy in head and neck cancer, J Clin Oncol, 1, 22, pp. 1743-1752, (2004)

[7]

List M.A., Bilir S.P., Functional outcomes in head and neck cancer, Semin Radiat Oncol, 14, 2, pp. 178-189, (2004)

[8]

Allison P.J., Locker D., Wood-Dauphinee S., Black M., Feine J.S., Correlates of health-related quality of life in upper aerodigestive tract cancer patients, Qual Life Res, 7, 8, pp. 713-722, (1998)

[9]

Hu K., Harrison L.B., Impact of anemia in patients with head and neck cancer treated with radiation therapy, Curr Treat Options Oncol, 6, pp. 31-45, (2005)

[10]

Herchenhorn D., Dias F.L., Advances in radiochemotherapy in the treatment of head and neck cancer, Rev Hosp Clin Fac Med Sao Paulo, 59, 1, pp. 39-46, (2004)

← 1 2 3 →